David W. Boyer

CIK: 0001909817

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (30.8%)

Position reduction

Option Exercises (M)8 (30.8%)

Derivative conversions

Awards (A)4 (15.4%)

Compensation grants

Other (G, F, J, C, D, …)6 (23.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NBIX

NEUROCRINE BIOSCIENCES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

NBIX
NEUROCRINE BIOSCIENCES INC
Sep 14, 2026
Sale(S)
Direct
826 shares at avg. $157.45$130K
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $156.22$302K
NBIX
NEUROCRINE BIOSCIENCES INC
Sep 11, 2026
Award(A)
Direct
3.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
May 26, 2026
Sale(S)
Direct
3.9K shares at avg. $156.64$609K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
978 shares at avg. $124.12$121K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
5.4K shares at avg. $124.12$668K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
1.5K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Tax Payment(F)
Direct
832 shares at avg. $124.12$103K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Exercise(M)
Direct
1.8K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2026
Award(A)
Direct
10K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Exercise(M)
Direct
1.6K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2026
Tax Payment(F)
Direct
864 shares at avg. $123.10$106K
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $136.06$162K
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2026
Exercise(M)
Direct
2.1K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Exercise(M)
Direct
1.8K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Sale(S)
Direct
955 shares at avg. $116.79$112K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Exercise(M)
Direct
1.5K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 13, 2025
Sale(S)
Direct
830 shares at avg. $116.69$97K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2025
Award(A)
Stock Option
Direct
34.2K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 12, 2025
Award(A)
Restricted Stock Unit
Direct
6.4K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 10, 2025
Sale(S)
Direct
700 shares at avg. $118.31$83K
NBIX
NEUROCRINE BIOSCIENCES INC
Feb 8, 2025
Exercise(M)
Direct
1.3K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2025
Exercise(M)
Direct
2.1K shares-
NBIX
NEUROCRINE BIOSCIENCES INC
Jan 31, 2025
Sale(S)
Direct
1.1K shares at avg. $152.94$169K
NBIX
NEUROCRINE BIOSCIENCES INC
Oct 3, 2024
Sale(S)
Direct
1.3K shares at avg. $113.66$147K

		Type	Shares	Price		Ownership
Sep 14, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	826	$157.45	$130,051	Direct
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,936	$156.22	$302,442	Direct
Sep 11, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	3,587	-	$0	Direct
May 26, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	3,888	$156.64	$609,023	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	978	$124.12	$121,389	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	5,378	$124.12	$667,517	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,541	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	832	$124.12	$103,268	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,811	-	$0	Direct
Feb 13, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Award(A)	9,968	-	$0	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,600	-	$0	Direct
Feb 12, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	864	$123.10	$106,358	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Tax Payment(F)	1,189	$136.06	$161,775	Direct
Jan 31, 2026	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,096	-	$0	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,811	-	-	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	955	$116.79	$111,538	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,541	-	-	Direct
Feb 13, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	830	$116.69	$96,849	Direct
Feb 12, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Stock Option	34,153	-	-	Direct
Feb 12, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Award(A) Restricted Stock Unit	6,401	-	-	Direct
Feb 10, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	700	$118.31	$82,820	Direct
Feb 8, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	1,329	-	-	Direct
Jan 31, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Exercise(M)	2,096	-	-	Direct
Jan 31, 2025	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	1,104	$152.94	$168,849	Direct
Oct 3, 2024	NBIX NEUROCRINE BIOSCIENCES INC	Sale(S)	1,295	$113.66	$147,190	Direct

1-25 of 26 transactions

About Boyer David W.

Boyer David W. (SEC CIK 0001909817) files insider reports with the SEC as Chief Corp. Affairs Officer of NEUROCRINE BIOSCIENCES INC (NBIX).

Signal8 holds 9 ownership filings by Boyer David W., all Form 4s, filed between Sep 17, 2024 and Sep 15, 2026. Those filings report 26 transactions, from Sep 13, 2024 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Boyer David W.'s filings is in SAN DIEGO, CA.

Recent filings by Boyer David W.

Sep 14, 2026: Open-market sale of NBIX shares (Form 4, code S).
Sep 11, 2026: Tax withholding of NBIX shares (Form 4, code F).
Sep 11, 2026: Grant or award of NBIX shares (Form 4, code A).
May 26, 2026: Open-market sale of NBIX shares (Form 4, code S).
Feb 13, 2026: Tax withholdings of NBIX shares (2 lines, Form 4, code F).

Other insiders filing for NEUROCRINE BIOSCIENCES INC (NBIX)

MORROW GEORGE J, Director
Gano Kyle, Chief Executive Officer
ROBERTS EIRY, Chief Medical Officer
Onyia Jude, Chief Scientific Officer
Lippoldt Darin, Chief Legal Officer
Keswani Sanjay Chandru, Chief Medical Officer

How to read Form 4 transaction codes